Skadden advised TUHU Car Inc. in the transaction. TUHU Car Inc. announced its listing and initial public offering on the Main Board of the Hong Kong...
TUHU Car’s $138 Million Initial Public Offering
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO....
Li Auto’s HKD11.8 Billion Hong Kong Dual Primary Listing
King & Wood Mallesons and Kirkland advised the joint sponsors and underwriters on Li Auto Inc.’s listing. Skadden advised Li Auto Inc. On 12 August 2021,...
DiDi Global’s $4.4 Billion Initial Public Offering
Skadden advised DiDi Global on the deal while Simpson Thacher represented the underwriters. DiDi Global, Inc., the world’s leading mobility technology platform, executed its initial public...
Zhejiang Expressway’s €230 Million Convertible Bonds Offering
Davis Polk advised Zhejiang Expressway on the deal. Zhejiang Expressway Co., Ltd. executed its Regulation S offering of €230 million zero coupon H Share convertible bonds...
JOINN Laboratories’ $844 Million Initial Public Offering
Davis Polk advised JOINN Laboratories on the deal while Sullivan & Cromwell LLP represented the sole sponsor and the underwriters. JOINN Laboratories (China) Co., Ltd. finalized...
InnoCare Pharma Limited’s $287 Million Initial Public Offering
Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock...